Versant Venture Management, LLC Adverum Biotechnologies, Inc. Transaction History
Versant Venture Management, LLC
- $71.7 Million
- Q1 2024
A detailed history of Versant Venture Management, LLC transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 506,822 shares of ADVM stock, worth $4.01 Million. This represents 9.99% of its overall portfolio holdings.
Number of Shares
506,822
Previous 5,068,233
90.0%
Holding current value
$4.01 Million
Previous $3.8 Million
88.53%
% of portfolio
9.99%
Previous 5.58%
Shares
5 transactions
Others Institutions Holding ADVM
# of Institutions
5Shares Held
3.6MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA2.01MShares$15.9 Million2.99% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.07MShares$8.47 Million0.79% of portfolio
-
Pinz Capital Management, LP New York, NY15.7KShares$124,3440.03% of portfolio
-
American Portfolios Advisors Holbrook, NY1.15KShares$9,1080.0% of portfolio
About Adverum Biotechnologies, Inc.
- Ticker ADVM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,333,600
- Market Cap $787M
- Description
- Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...